› Forums › General Melanoma Community › Reporter needs Roche/Plexxikon Phase III patients
- This topic has 3 replies, 1 voice, and was last updated 13 years ago by phyllispj.
- Post
-
- July 28, 2010 at 9:36 pm
I have been contacted by a national reporter interested in speaking with a couple of patients who are currently enrolled in the Phase III study of the BRAF inhibiter in development from Roche/Plexxikon. This reporter wants to hear a patient’s perspective on the trial. This is a great opportunity to have unfiltered patient input into the clinical trial process.
If you are please send me an e-mail and I will forward it along to the reporter.
Thanks
Tim–MRF
I have been contacted by a national reporter interested in speaking with a couple of patients who are currently enrolled in the Phase III study of the BRAF inhibiter in development from Roche/Plexxikon. This reporter wants to hear a patient’s perspective on the trial. This is a great opportunity to have unfiltered patient input into the clinical trial process.
If you are please send me an e-mail and I will forward it along to the reporter.
Thanks
Tim–MRF
- Replies
-
-
- November 23, 2011 at 10:15 pm
I am often to running a blog and i really recognize your content. The article has actually peaks my interest. I’m going to bookmark your web site and maintain checking for new information.
shopify themes gunmetal bigcommerce vs shopify Agelong green geeks review Tibetan -
- November 23, 2011 at 10:15 pm
I am often to running a blog and i really recognize your content. The article has actually peaks my interest. I’m going to bookmark your web site and maintain checking for new information.
shopify themes gunmetal bigcommerce vs shopify Agelong green geeks review Tibetan -
- November 23, 2011 at 10:15 pm
I am often to running a blog and i really recognize your content. The article has actually peaks my interest. I’m going to bookmark your web site and maintain checking for new information.
shopify themes gunmetal bigcommerce vs shopify Agelong green geeks review Tibetan
-
- You must be logged in to reply to this topic.